We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
After MDMA and psilocybine has been supplied, you have specific responsibilities.
You must:
- maintain accurate records
- monitor product use
- report supply data every six months
- report adverse events.
We oversee these activities to ensure that unapproved therapeutic goods are supplied appropriately.
Understanding and fulfilling your obligations is crucial for maintaining compliance.
You must meet certain obligations to legally supply therapeutic goods in Australia. This section contains guidance and information specific to unapproved therapeutic goods. You may also have to meet obligations that apply to all unapproved therapeutic goods and all products.